checkAd

     125  0 Kommentare Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial - Seite 3



    Noted products are trademarks or registered trademarks of their respective owners

    Contact Information:
    Amphastar Pharmaceuticals, Inc.
    Bill Peters
    Chief Financial Officer
    (909) 980-9484 

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial - Seite 3 RANCHO CUCAMONGA, Calif., April 27, 2020 (GLOBE NEWSWIRE) - Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”),  today announces that the U.S. Food and Drug Administration (“FDA”) has granted approval of its Abbreviated New Drug …